Sep 1, 2026Effective9999999995-26-002849
All companies
Trinity Biotech Plc
TRIBPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $6.42M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: News reports, SEC EDGAR, Nasdaq
IPO Calendar · NasdaqIPO
TRIBPrice
$7.75
24h
-0.51%
Valuation
$6.42M
24h volume
$82.99K
Type
IPO
IPO Calendar · updated 45m ago
About Trinity Biotech Plc
Trinity Biotech Plc is its products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood.
SEC IPO filings
EffectiveEDGAR filings resolved from TRIB / CIK 0000888721.
F-1/AFORM F-1/A
Aug 21, 2026Amended0001554855-26-001911
424B3424B3
Jun 23, 2026Final prospectus0001554855-26-001392
424B3424B3
Jun 18, 2026Final prospectus0001554855-26-001370
424B3424B3
Jun 15, 2026Final prospectus0001554855-26-001334
Jun 10, 2026Effective9999999995-26-001939
RWFORM RW
Jun 3, 2026Withdrawn0001554855-26-001226
F-1/AFORM F-1/A
Jun 3, 2026Amended0001554855-26-001225
424B3424B3
May 26, 2026Final prospectus0001554855-26-001128
May 22, 2026Effective9999999995-26-001746
CORRESPfilename1.htm
May 20, 2026SEC correspondence0001554855-26-001094
UPLOADfilename1.pdf
May 20, 2026SEC correspondence0000000000-26-005165
Trinity Biotech Plc IPO — frequently asked questions
- When did Trinity Biotech Plc go public?
- Trinity Biotech Plc has already gone public and now trades publicly on Nasdaq under the ticker TRIB.
- Can I buy Trinity Biotech Plc stock?
- Yes — Trinity Biotech Plc is publicly traded on Nasdaq as TRIB. You can follow its live price, valuation and post-IPO performance above.
- What is Trinity Biotech Plc's valuation?
- Trinity Biotech Plc's most recent valuation tracked here is $6.42M, derived from live market prices.